S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
El-Khoueiry, A B, Rankin, C, Siegel, A B, Iqbal, S, Gong, I-Y, Micetich, K C, Kayaleh, O R, Lenz, H-J, Blanke, C DVolume:
110
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2013.801
Date:
February, 2014
File:
PDF, 232 KB
english, 2014
File converter
More search results
More benefits 
